Study identifier:NIS-CCH-DUM-2008/2
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Management of cardiovascular risk factors
Cardiovascular risk factors
-
Yes
-
All
1492
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Dec 2014 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
This practical experience should report a retrospective collection of data regarding cardiovascular risk factors of cardiovascular diseases. The goal is an evaluation of the development of the risk profile of cardiovascular patients with simultaneous treatment of hypertension and hyperlipidemia
Location
Location
Affoltern am Albis, ZH, Switzerland
Location
Andeer, GR, Switzerland
Location
Arbedo, TI, Switzerland
Location
Bassins, VD, Switzerland
Location
Bellinzona, TI, Switzerland
Location
Claro, TI, Switzerland
Location
Coldrerio, TI, Switzerland
Location
Feldmeilen, ZH, Switzerland
Arms | Assigned Interventions |
---|---|
1 Patients with hypertension and hyperlipidemia and other CV risk factors | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.